Bulletin of the World Health Organization

Maternal multiple micronutrient supplementation and pregnancy outcomes in developing countries: meta-analysis and meta-regression

Kosuke Kawai, Donna Spiegelman, Anuraj H Shankar & Wafaie W Fawzi

Volume 89, Number 6, June 2011, 402-411B

Table 1. Characteristics of randomized controlled trials examining the effect of maternal micronutrient supplementation on pregnancy outcomes in developing countries

Study Country No. of women Intervention Control Compliance (%) Loss to follow-up (%) Weeks of gestation at enrolment (mean ± SD)
Fawzi et al., 199816 United Republic of Tanzania 1075 HIV+ 8 vitamins in multiples of RDAa Iron (60 mg) and folic acid (5 mg) 91 6 20.3 ± 3.4
Christian et al., 200317,18 Nepal (Sarlahi) 1978 15 micronutrientsb Iron (60 mg) and folic acid (400 µg) 75 6 11.4 ± 5.1
Ramakrishnan et al., 200319 Mexico 873 13 micronutrientsc Iron (60 mg) 95 26 9.2 ± 3.0
Friis 200420 Zimbabwe 1669 (1 135 HIV− and 534 HIV+) 13 micronutrientsd Iron and folic acid NA 34 29.2
Kaestel et al.,200521 Guinea Bissau 2100 UNIMMAP in 1 or 2 doses of RDAe Iron (60 mg) and folic acid (400 µg) 76 19 22 ± 7
Osrin et al., 200522 Nepal (Janakpur) 1200 UNIMMAPe Iron (60 mg) and folic acid (400 µg) NA 3 16.2 ± 3.0
Gupta et al., 200723 India 200 undernourished 29 micronutrientsf Iron (60 mg) and folic acid (500 µg) 85 15 27.9
Zagré et al., 200724 Niger 3670 UNIMMAPe Iron (60 mg) and folic acid (400 µg) 79 31 10
Fawzi et al., 200725 United Republic of Tanzania 8468 HIV− 8 vitamins in multiples of RDAa Iron (60 mg) and folic acid (5 mg) 88 1 21.3 ± 3.5
Shankar et al., 200826 Indonesia 31 290 UNIMMAPe Iron (30 mg) and folic acid (400 µg) 85 6 20.9
Zeng et al., 200827 China 3811 UNIMMAPe Iron (60 mg) and folic acid (400 µg) 92 8 13.8 ± 5.6
Roberfroid et al., 200828 Burkina Faso 1426 UNIMMAPe Iron (60 mg) and folic acid (400 µg) NA 4 17.3 ± 8.0
Bhutta et al., 200929 Pakistan 2378 UNIMMAPe Iron (60 mg) and folic acid (400 µg) 76 11 12.2 ± 3.0
Sunawang et al., 20099,10,30 Indonesia (Indramayu) 1694 UNIMMAPe Iron (60 mg) and folic acid (400 µg) NA NA 14.4
Tofail et al., 20099,10 Bangladesh 2412 UNIMMAPe Iron (30 mg) and folic acid (400 µg) NA NA 14.6

HIV, human immunodeficiency virus; NA, not available; RDA, recommended dietary allowance; SD, standard deviation; UNIMMAP, UNICEF/WHO/United Nations University international multiple micronutrient preparation.

a Used vitamins B1 (20 mg), B2 (20 mg), B6 (25 mg), B12 (50 µg), C (500 mg), E (30 mg) and niacin (100 mg) plus iron (60 mg) and folic acid (60.8 mg).

b Used vitamins A (1000 µg), D (10 µg), E (10 mg), B1 (1.6 mg), B2 (1.8 mg), B6 (2.2 mg), B12 (2.6 µg), C (100 mg) and niacin (20 mg) plus zinc (30 mg), copper (2 mg), vitamin K (65 µg), magnesium (100 mg), iron (60 mg) and folic acid (400 µg).

c Used vitamins A (2150 IU), D (309 IU), E (5.73 IU), B1 (0.93 mg), B2 (1.87 mg), B6 (1.94 mg), B12 (2.04 µg), C (66.5 mg) and niacin (15.5 mg) plus zinc (12.9 mg), magnesium (252 mg), iron (62.4 mg) and folic acid (215 µg).

d Used β-carotene (3.5 mg), vitamins A (3000 IU), D (5 µg), E (10 mg), B1 (1.5 mg), B2 (1.6 mg), B6 (2.2 mg), B12 (4.0 µg), C (80 mg) and niacin (17 mg) plus zinc (15 mg), copper (1.2 µg), selenium (65 µg) and folic acid (5 mg).

e International multiple micronutrient preparation containing vitamins A (800 µg), D (5 µg), E (10 mg), B1 (1.4 mg), B2 (1.4 mg), B6 (1.9 mg), B12 (2.6 µg) C (70 mg) and niacin (18 mg) plus zinc (15 mg), copper (2 mg), selenium (65 µg), iodine (150 µg), iron (30 mg) and folic acid (400 µg).

f Used β-carotene (2500 IU), vitamins B1 (1 mg), B2 (1.5 mg), B6 (1 mg), B12 (1 µg), C (50 mg), D (200 IU), E (7.5 mg), calcium (5 mg), nicotinamide (20 mg), biotin (30 µg), zinc (15 mg), potassium iodide (0.15 mg), magnesium oxide (100 mg), magnese sulfate (2.5 mg), copper (2 mg), calcium (162 mg), phosphorus (125 mg), potassium (40 mg), chloride (36.3 mg), chromium (25 µg), molybdenum (25 µg), spdium selenate (30 µg), nickel (5 µg), silicon dioxide (2 mg), vanadium (10 µg), boron (150 µg), iron (70 mg) and folic acid (900 µg).